Show simple item record

Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic

dc.contributor.authorSahu, Kamal Kant
dc.contributor.authorSiddiqui, Ahmad Daniyal
dc.contributor.authorRezaei, Nima
dc.contributor.authorCerny, Jan
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:49Z
dc.date.available2022-08-23T15:45:49Z
dc.date.issued2020-07-03
dc.date.submitted2020-07-08
dc.identifier.citation<p>Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251. Epub ahead of print. PMID: 32619062. <a href="https://doi.org/10.1002/jmv.26251">Link to article on publisher's site</a></p>
dc.identifier.issn0146-6615 (Linking)
dc.identifier.doi10.1002/jmv.26251
dc.identifier.pmid32619062
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27615
dc.description.abstractIt is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32619062&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1002/jmv.26251
dc.subjectCOVID-19
dc.subjectCoronavirus
dc.subjectEpidemiology
dc.subjectImmune responses
dc.subjectPandemics
dc.subjectPlasma cell
dc.subjectSARS coronavirus
dc.subjectVirus classification
dc.subjectHealth Services Administration
dc.subjectHematology
dc.subjectHemic and Lymphatic Diseases
dc.subjectImmune System Diseases
dc.subjectInfectious Disease
dc.subjectMedical Microbiology
dc.subjectVirus Diseases
dc.titleChallenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic
dc.typeJournal Article
dc.source.journaltitleJournal of medical virology
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/66
dc.identifier.contextkey18421079
html.description.abstract<p>It is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.</p>
dc.identifier.submissionpathcovid19/66
dc.contributor.departmentDivision of Hematology and Oncology, Department of Medicine


This item appears in the following Collection(s)

Show simple item record